ミズホメディーの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/11/08 | 3,140 | 3,145 | 3,115 | 3,125 | +20 | +0.6% | 34,500 |
2022/11/07 | 3,125 | 3,140 | 3,105 | 3,105 | +15 | +0.5% | 38,400 |
2022/11/04 | 3,120 | 3,120 | 3,050 | 3,090 | -30 | -1% | 55,800 |
2022/11/02 | 3,135 | 3,145 | 3,105 | 3,120 | -20 | -0.6% | 43,600 |
2022/11/01 | 3,130 | 3,175 | 3,130 | 3,140 | +10 | +0.3% | 41,800 |
2022/10/31 | 3,155 | 3,165 | 3,115 | 3,130 | -5 | -0.2% | 43,200 |
2022/10/28 | 3,135 | 3,165 | 3,115 | 3,135 | -5 | -0.2% | 29,000 |
2022/10/27 | 3,145 | 3,200 | 3,140 | 3,140 | ±0 | ±0% | 37,400 |
2022/10/26 | 3,140 | 3,190 | 3,140 | 3,140 | -5 | -0.2% | 54,400 |
2022/10/25 | 3,150 | 3,170 | 3,130 | 3,145 | +30 | +1% | 35,400 |
2022/10/24 | 3,200 | 3,210 | 3,115 | 3,115 | -45 | -1.4% | 87,800 |
2022/10/21 | 3,120 | 3,180 | 3,120 | 3,160 | +25 | +0.8% | 54,600 |
2022/10/20 | 3,105 | 3,170 | 3,065 | 3,135 | +20 | +0.6% | 77,700 |
2022/10/19 | 3,085 | 3,145 | 3,080 | 3,115 | +20 | +0.6% | 47,600 |
2022/10/18 | 3,000 | 3,105 | 3,000 | 3,095 | +105 | +3.5% | 82,000 |
2022/10/17 | 3,010 | 3,015 | 2,923 | 2,990 | -30 | -1% | 101,300 |
2022/10/14 | 3,055 | 3,075 | 2,996 | 3,020 | +80 | +2.7% | 82,000 |
2022/10/13 | 2,960 | 3,035 | 2,940 | 2,940 | +40 | +1.4% | 97,900 |
2022/10/12 | 2,883 | 2,903 | 2,865 | 2,900 | +12 | +0.4% | 21,800 |
2022/10/11 | 2,880 | 2,913 | 2,859 | 2,888 | +18 | +0.6% | 46,400 |
2022/10/07 | 2,770 | 2,883 | 2,763 | 2,870 | +99 | +3.6% | 75,700 |
2022/10/06 | 2,830 | 2,830 | 2,770 | 2,771 | -57 | -2% | 90,400 |
2022/10/05 | 2,811 | 2,829 | 2,784 | 2,828 | +27 | +1% | 37,500 |
2022/10/04 | 2,791 | 2,821 | 2,786 | 2,801 | +56 | +2% | 57,200 |
2022/10/03 | 2,753 | 2,758 | 2,698 | 2,745 | +3 | +0.1% | 51,400 |
2022/09/30 | 2,760 | 2,775 | 2,725 | 2,742 | -22 | -0.8% | 55,700 |
2022/09/29 | 2,725 | 2,782 | 2,710 | 2,764 | +89 | +3.3% | 50,300 |
2022/09/28 | 2,820 | 2,820 | 2,646 | 2,675 | -122 | -4.4% | 146,400 |
2022/09/27 | 2,842 | 2,850 | 2,797 | 2,797 | +1 | ±0% | 58,100 |
2022/09/26 | 2,828 | 2,832 | 2,772 | 2,796 | +16 | +0.6% | 79,100 |
2022/09/22 | 2,810 | 2,810 | 2,772 | 2,780 | -39 | -1.4% | 36,400 |
2022/09/21 | 2,816 | 2,832 | 2,786 | 2,819 | +3 | +0.1% | 29,400 |
2022/09/20 | 2,864 | 2,865 | 2,769 | 2,816 | -29 | -1% | 90,700 |
2022/09/16 | 2,901 | 2,926 | 2,844 | 2,845 | -53 | -1.8% | 46,900 |
2022/09/15 | 2,895 | 2,926 | 2,883 | 2,898 | +2 | +0.1% | 34,100 |
2022/09/14 | 2,865 | 2,908 | 2,810 | 2,896 | +6 | +0.2% | 50,000 |
2022/09/13 | 2,890 | 2,917 | 2,884 | 2,890 | +7 | +0.2% | 34,100 |
2022/09/12 | 2,863 | 2,883 | 2,837 | 2,883 | +43 | +1.5% | 38,900 |
2022/09/09 | 2,834 | 2,865 | 2,810 | 2,840 | +6 | +0.2% | 50,800 |
2022/09/08 | 2,835 | 2,852 | 2,814 | 2,834 | -8 | -0.3% | 53,900 |
2022/09/07 | 2,915 | 2,915 | 2,830 | 2,842 | -91 | -3.1% | 75,800 |
2022/09/06 | 2,896 | 2,935 | 2,870 | 2,933 | +37 | +1.3% | 70,000 |
2022/09/05 | 2,955 | 3,000 | 2,869 | 2,896 | -98 | -3.3% | 139,000 |
2022/09/02 | 3,065 | 3,100 | 2,992 | 2,994 | -16 | -0.5% | 60,900 |
2022/09/01 | 3,000 | 3,035 | 2,930 | 3,010 | +13 | +0.4% | 91,800 |
2022/08/31 | 2,993 | 3,030 | 2,971 | 2,997 | -13 | -0.4% | 112,800 |
2022/08/30 | 3,020 | 3,020 | 2,991 | 3,010 | -10 | -0.3% | 46,100 |
2022/08/29 | 2,988 | 3,025 | 2,987 | 3,020 | -30 | -1% | 51,300 |
2022/08/26 | 3,040 | 3,070 | 3,025 | 3,050 | -15 | -0.5% | 45,700 |
2022/08/25 | 3,040 | 3,070 | 3,030 | 3,065 | +35 | +1.2% | 39,100 |
601~
650
件表示中 / 2281件
類似銘柄と比較する
現在ご覧いただいている「ミズホメディ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ミズホメディ | 147,700円 | +1.2% | -13.9% | 5.75% | 8.71倍 | 1.62倍 |
|
体外検査薬専業、感染症抗体、遺伝子検査機器、試薬開発。新型コロナで急成長、妊娠検査薬も |
ダイト | 205,500円 | +4.5% | -33.7% | 3.41% | 20.70倍 | 0.60倍 |
|
医薬品の原薬製造販売や、製剤の製造受託が主力。ジェネリック(後発医薬品)メーカー向け強い |
ヘリオス | 29,300円 | +150.0% | - | 0.00% | - | 14.41倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
アンジェス | 6,900円 | +110.0% | - | 0.00% | - | 11.22倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
扶桑薬 | 230,400円 | +8.3% | +98.1% | 3.56% | 7.57倍 | 0.52倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア5割。後発薬や製造受託も展開 |
市場注目の銘柄
チャート関連のコラム